Association of ferritin and lipids with C-reactive protein

American Journal of Cardiology

Volumn 93, Issue 5, 2004, Pages 559-562

  Mainous III, Arch G ^a   Wells, Brian J ^b   Everett, Charles J ^b   Gill, James M ^b   King, Dana E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; GENDER; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; UNITED STATES;

ADULT; AGED; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FERRITINS; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NUTRITION SURVEYS; TRIGLYCERIDES; UNITED STATES;

EID: 1442324362     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.018     Document Type: Article

References (29)

1. Brown N.S., Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3:2001;323-327.
2. Nunez M.T., Tapia V., Toyokuni S., Okada S. Iron-induced oxidative damage in colon carcinoma (Caco-2) cells. Free Rad Res. 34:2001;57-68.
3. Esterbauer H., Wag G., Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull. 49:1993;566-576.
4. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915-924.
5. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1998;1-15.
6. Ehara S., Ueda M., Naruko T., Haze K., Iton A., Otsuka A., Komatsu R., Matsuo T., Itabe H., Takano T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 103:2001;1955-1960.
7. Iuliano L., Micheletta F., Violi F. Low-density lipoprotein oxidation. Ital Heart J. 2:2001;867-872.
8. Sherer Y., Tenenbaum A., Praprotnik S., Shemesh J., Blank M., Fisman E.Z., Harats D., George J., Levy Y., Peter J.B., Motio M., Shoenfeld Y. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology. 95:2001;20-24.
9. Vasankari T., Ahotupa M., Toikka J., Mikkola J., Irjala K., Pasanen P., Neuvonen K., Raitakari O., Vikari J. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men lower levels of oxidized LDL with statin therapy. Atherosclerosis. 155:2001;403-412.
10. Tsimikas S., Witztum J.L. Measuring circulating oxidized low density lipoprotein to evaluate coronary risk. Circulation. 103:2001;1930-1932.
11. Rehema A., Zilmer M., Zilmer K., Kullisaar T., Vihalemm T. Could long-term alimentary iron overload have an impact on the parameters of oxidative stress? A study on the basis of a village in southern Estonia. Ann Nutr Metab. 42:1998;40-43.
12. Glei M., Latunde-Dada G.O., Klinder A., Becker T.W., Hermann U., Voigt K., Pool-Zobel B.L. Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat Res. 519:2002;151-161.
13. Fischer J.G., Glauert H.P., Yin T., Sweeney-Reeves M.L., Larmonier N., Black M.C. Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14, 643. J Nutr. 132:2002;2525-2531.
14. Day S.M., Duquaine D., Mundada L.V., Menon R.G., Khan B.V., Rajagopalan S., Fay W.P. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation. 107:2003;2601-2606.
15. Steinberg D., Witztum J.L. Is the oxidative modification hypothesis relevant to human aterosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 105:2002;2107-2111.
16. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 97:1998;2007-2011.
17. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis. JAMA. 285:2001;2481-2485.
18. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 347:2002;1557-1565.
19. Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension. 39:2002;777-780.
20. Addison G., Beamish M., Hales C. An immunoradiometric assay for ferritin in the serum of normal patients and patients with iron deficiency and iron overload. J Clin Pathol. 25:1972;326.
21. Jeong H, Blackmore J, Lewin N. Ferritin Immunoradiometric Assay. U.S. Patent No. 4, 244, 940
22. Bachorik P.S., Kwiterovich P.O. The measurement of plasma cholesterol, low density lipoprotein and high density lipoprotein cholesterol. Hommes F.A. Techniques in Diagnostic Human Biochemical Genetics A Laboratory Manual. 1991;425-429 Wiley-Liss, New York, NY.
23. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington DC: National Institutes of Health, 2002
24. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O. III, Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., et al. AHA/CDC scientific statement. Markers of inflammation and cardiovascular disease - application to clinical and public health practice. Circulation. 107:2003;499-511.
25. Kunitake S.T., Jarvis M.R., Hamilton R.L., Kane J.P. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci USA. 89:1992;6993-6997.
26. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
27. Hong M.K., Romm P.A., Reagan K., Green C.E., Rackley C.E. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 68:1991;1646-1650.
28. Kervinen H., Palosuo T., Manninen V., Tenkanen L., Vaarala O., Manttari M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J. 141:2001;580-585.
29. Abdelmouttaleb I., Danchin N., Ilardo C., Aimone-Gastin I., Angioi M., Lozniewski A., Loubinoux J., LeFaou A., Gueant J.L. C-reactive protein and coronary artery disease additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J. 137:1999;346-351.